| 2.8833 -0.107 (-3.57%) | 04-23 09:52 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 3.84 | 1-year : | 4.19 |
| Resists | First : | 3.29 | Second : | 3.58 |
| Pivot price | 2.99 |
|||
| Supports | First : | 2.8 | Second : | 2.33 |
| MAs | MA(5) : | 2.9 |
MA(20) : | 3.05 |
| MA(100) : | 3.62 |
MA(250) : | 6.42 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 18  |
D(3) : | 15 |
| RSI | RSI(14): 42.7 |
|||
| 52-week | High : | 24.6 | Low : | 2.39 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ CJJD ] has closed above bottom band by 21.2%. Bollinger Bands are 66.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 11 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 3 - 3.01 | 3.01 - 3.02 |
| Low: | 2.97 - 2.98 | 2.98 - 3 |
| Close: | 2.98 - 3 | 3 - 3.02 |
China Jo-Jo Drugstores, Inc., together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through four segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items. The company also operates licensed doctors of Western medicine and TCM on site for consultation, examination, and treatment of common ailments at scheduled hours. In addition, it operates online drugstore that retails OTC drugs and nutritional supplements, as well as sells products through third-party platforms. Further, the company distributes third-party pharmaceutical products primarily to trading companies, as well as cultivates and wholesales herbs used for TCM. As of March 31, 2021, it had 109 retail pharmacies under the Jiuzhou Grand Pharmacy name, as well as 4 drugstores. The company was founded in 2003 and is headquartered in Hangzhou, the People's Republic of China.
Sat, 20 Apr 2024
StockNews.com Initiates Coverage on China Jo-Jo Drugstores (NASDAQ:CJJD) - Defense World
Tue, 19 Mar 2024
China Jo-Jo Drugstores meets Nasdaq minimum bid price - Investing.com India
Tue, 05 Mar 2024
Why Paymentus Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Markets Insider
Wed, 19 Apr 2023
China Jo Jo Drugstores CJJD crashes 85% on disaster of a fundraise - Dhaka Tribune
Wed, 19 Apr 2023
3 Investors Betting Big on China Jo-Jo Drugstores (CJJD) Stock - InvestorPlace
Tue, 04 Oct 2022
Consumer Defensive Stocks Making Moves Tuesday: BRSH, RAD, OCDDY, FARM, RIBT, YQ, VWE, CJJD - InvestorsObserver
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Pharmaceuticals
|
|
| Shares Out | 2 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 31.4 (%) |
| Held by Institutions | 1.6 (%) |
| Shares Short | 13 (K) |
| Shares Short P.Month | 3 (K) |
| EPS | -4.41 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 11.22 |
| Profit Margin | -13.9 % |
| Operating Margin | 0.3 % |
| Return on Assets (ttm) | -12.4 % |
| Return on Equity (ttm) | -108.8 % |
| Qtrly Rev. Growth | 8 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 71.6 |
| EBITDA (p.s.) | -8.82 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -4 (M) |
| Levered Free Cash Flow | 5 (M) |
| PE Ratio | -0.66 |
| PEG Ratio | 0 |
| Price to Book value | 0.25 |
| Price to Sales | 0.04 |
| Price to Cash Flow | -1.73 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|